Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade in recurrent or metastatic nasopharyngeal carcinoma
NCT00305734Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2006
- Primary completion
- Jul 2007
- Countries
- 1
01
Overview
Phase 2, open-label trial of bortezomib in nasopharyngeal carcinoma (NPC), sponsored by National Cancer Institute. Started Aug 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00305734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305734.